Interestingly, for breast cancer patients, we found a significant association of high nTRAIL-R1 expression with lower tumor stage, less lymphovascular invasion, and reduced rate of local tumor recurrence, suggesting the anti-tumor role of nuclear TRAIL-R1 in this context. Here, TNFRSF10A is linked to neoplasm.